Company intelligence / Profile preview

Condroflex

São José da Lapa, Minas Gerais, Brazil

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Laboratório Globo is a Brazilian pharmaceutical company that develops, manufactures, and markets a wide range of generic and branded medications. One of its most prominent products is Condroflex, a widely used treatment for osteoarthritis and joint degeneration containing glucosamine and chondroitin. The company operates a significant manufacturing facility in Minas Gerais and focuses on providing affordable healthcare solutions across various therapeutic areas, including orthopedics, cardiology, and infectious diseases. Laboratório Globo is a key player in the Brazilian retail pharma market, maintaining a robust distribution network for its diverse portfolio of over 200 products.

Therapeutic areas: Rheumatology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Condroflex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Condroflex.

Explore the full profile